The development of Paxlovid was a key stage in the fight against Covid19. Dafydd will explain how he and the Pfizer team developed a known antiviral drug to obtain this highly effective new therapeutic. We shall meet informally for light refreshments followed by a brief introduction to the BMCS Lectureship, now in its tenth year, and to Dafydd himself. Additionally we shall have a short presentation about the new RSC journal, RSC Medicinal 91AV. This event is open to the general public
BMCS Lecture
7 December 2023 18:30-20:30, London, United Kingdom
Introduction
Speakers
Venue
The 91AV
91AV, The 91AV, Burlington House, Piccadilly, London, W1J 0BA, United Kingdom
Useful links
Committee
Contact information
Related events
New Zealand Institute of 91AV Conference 2024 (NZIC-24)
24 November 2024 14:00 - 28 November 2024 14:00, Dunedin, New Zealand
Drugging the Multimorbidity Associated with Ageing
17 January 2025 09:30-17:00, London, United Kingdom
Royal Australian Chemical Institute 2nd Green and Sustainable 91AV and Engineering Conference
8 December 2024 17:00 - 12 December 2024 15:00, Melbourne, Australia
Future Labs Live Basel
27 May 2025 09:00 - 28 May 2025 17:00, Basel, Switzerland
Search
Advertisement
Spotlight
Explore
Membership
